ARGENT CAPITAL MANAGEMENT LLC

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1120926 ST LOUIS, MO

Position in HALO

as of Jun 30, 2026 · filed Jul 15, 2026 Compact

Position Value

$427,510

-$157,650 QoQ

Shares Held

5,462

-39.7% QoQ

Ownership

0.005%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#410

of 664 holders

Holding Since

Sep 2020

16 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ARGENT CAPITAL MANAGEMENT LLC holds $49,840,633 across 3 Biotechnology names. HALO ranks #3 (0.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JAZZ	Jazz Pharmaceuticals plc	200,072	$48,211,349
2	LGND	Ligand Pharmaceuticals Inc	3,802	$1,201,774
3	HALO	Halozyme Therapeutics, Inc. This page	5,462	$427,510

16 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$427,510	5,462	-39.7%	Shares	Sole	2026-07-15
2026-03-31	$585,160	9,054	+52.2%	Shares	Sole	2026-05-21
2025-12-31	$400,435	5,950	-6.3%	Shares	Sole	2026-01-05
2025-09-30	$465,709	6,350	-50.1%	Shares	Sole	2025-10-14
2025-06-30	$661,382	12,714	+5.0%	Shares	Sole	2025-07-14
2025-03-31	$772,420	12,105	-5.7%	Shares	Sole	2025-07-14
2024-12-31	$613,928	12,841	+35.1%	Shares	Sole	2025-01-14
2024-09-30	$543,894	9,502	+13.9%	Shares	Sole	2024-10-23
2024-06-30	$436,996	8,346	+35.3%	Shares	Sole	2024-07-24
2022-03-31	$246,059	6,170	-1.6%	Shares	Sole	2022-05-11
2021-12-31	$252,116	6,270	+0.6%	Shares	Sole	2022-02-09
2021-09-30	$253,639	6,235	-0.8%	Shares	Sole	2021-11-08
2021-06-30	$285,401	6,285	-22.9%	Shares	Sole	2021-08-10
2021-03-31	$339,773	8,150	-7.0%	Shares	Sole	2021-05-12
2020-12-31	$374,139	8,760	-62.3%	Shares	Sole	2021-02-10
2020-09-30	$610,221	23,220	—	Shares	Sole	2020-11-10
No filing history on record for this holder in this stock.